Comparison of Varenicline and Cytisine effectiveness on nicotine smoking cessation in Primary health care - randomized controlled trial
Phase 1
- Conditions
- Tobacco addictionTherapeutic area: Psychiatry and Psychology [F] - Behaviours [F01]
- Registration Number
- EUCTR2019-003720-20-SI
- Lead Sponsor
- niversity of Zagreb School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- Not specified
- Target Recruitment
- 380
Inclusion Criteria
Patients will be eligible for our study if they are aged 18 or older, are current smokers, indicate a desire to stop smoking, and an interest in pharmacotherapy.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 380
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Younger than 18
Mental illness who cannot provide informed consent for the study
Pregnant or breastfeeding
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method